X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
CURE’s Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D Sufficiency Necessary to Reduce Immune-Mediated Damage such as Graft Versus Host Disease.
Lead Product(s): Vitamin D3
Therapeutic Area: Nutrition and Weight Loss Product Name: ImmunD3 Nutri-Strips
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 12, 2022
Details:
Collaboration will sell in Mexico a number of CURE’s OTC and medical compounds (sildenafil citrate) that utilize CUREform™, CURE’s patented drug delivery platform for oral thin film (OTF). Cure is in discussions with several large distributors in Mexico and Latin America.
Lead Product(s): Sildenafil Citrate
Therapeutic Area: Psychiatry/Psychology Product Name: CUREfilm Blue
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Milagro Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration March 03, 2022
Details:
CURE Pharmaceutical is the pioneering developer of CUREform, patented drug delivery platform that offers a no. of unique immediate & controlled-release drug delivery vehicles designed to improve drug efficacy, safety & patient experience for a wide range of active ingredients.
Lead Product(s): Tetrahydrocannabinol,Cannabidiol
Therapeutic Area: Psychiatry/Psychology Product Name: Canna
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 15, 2021
Details:
CUREfilm Blue™ utilizes the Company’s patented and proprietary fast-dissolving drug delivery platform, known as CUREfilm™, to deliver the active pharmaceutical ingredient (API) sildenafil citrate.
Lead Product(s): Sildenafil Citrate
Therapeutic Area: Psychiatry/Psychology Product Name: CUREfilm Blue
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 05, 2021
Details:
Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline
Lead Product(s): Sildenafil Citrate
Therapeutic Area: Endocrinology Product Name: CUREfilm Blue
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Axiom Capital Management
Deal Size: $10.0 million Upfront Cash: $4.0 million
Deal Type: Financing November 02, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
